Myocardial Infarction
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Quantification of circulating lncRNAs; MALAT1 (metastasis-associated lung adenocarcinoma transcript 1), MIAT (myocardial infarction associated transcript), and ANRIL (antisense non-coding RNA in the INK4 locus) was done by Real-time qRT-PCR.
|
30665334 |
2019 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
We discovered targeting MIAT remarkably enhanced H9c2 cell viability, decreased H/R-induced cell apoptosis and LDH leakage and significantly decreased I/R-induced myocardial infarct size, reduced myocardial apoptosis and enhanced the heart function.
|
30971184 |
2019 |
Myocardial Infarction
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
The long noncoding RNA myocardial infarction associated transcript (MIAT) has been shown to be a risk allele for myocardial infarction in a previous study.
|
31661125 |
2019 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
MIAT originally has been considered as an lncRNA to be associated with a susceptibility to myocardial infarction.
|
29345338 |
2018 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
The long noncoding RNA myocardial infarction associated transcript (MIAT) is involved in a number of diseases, including myocardial infarction and diabetic retinopathy.
|
29914974 |
2018 |
Myocardial Infarction
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
Myocardial infarction associated transcript (MIAT), which was recently found to demonstrate aberrant expression in various diseases, such as myocardial infarction, schizophrenia, ischemic stroke, diabetic complications, age-related cataract and cancers, is a novel disease-related lncRNA.
|
29534728 |
2018 |
Myocardial Infarction
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
These findings also promise that normalization of MIAT level may prove to be a therapeutic option for the treatment of MI-induced cardiac fibrosis and the associated cardiac dysfunction.
|
28198439 |
2017 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
Dysregulation of the lncRNA known as myocardial infarction-associated transcript (MIAT) has been associated with myocardial infarction.
|
26951817 |
2016 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
Myocardial infarction associated transcript (MIAT) is identified as lncRNAs, which is involved in various diseases, pathological and physiological processes, such as myocardial infarction, diabetic retinopathy, paranoid schizophrenia, microvascular dysfunction and formation of nuclear bodies, and neurogenic commitment.
|
26707210 |
2016 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
MIAT, originally isolated as a candidate gene for myocardial infarction, encodes lncRNA (termed MIAT).
|
27527866 |
2016 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
BEFREE |
Patients with ST-segment-elevation MI had lower levels of ANRIL (P<0.001), KCNQ1OT1 (P<0.001), myocardial infarction-associated transcript (P<0.001), and metastasis-associated lung adenocarcinoma transcript 1 (P=0.005) when compared with patients with non-ST-segment-elevation MI.
|
25035150 |
2014 |
Myocardial Infarction
|
0.500 |
GeneticVariation
|
disease |
GWASDB |
These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
|
17066261 |
2006 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
CTD_human |
These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
|
17066261 |
2006 |
Myocardial Infarction
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
|
17066261 |
2006 |
Myocardial Infarction
|
0.500 |
Biomarker
|
disease |
LHGDN |
These results indicate that the altered expression of MIAT by the SNP may play some role in the pathogenesis of MI.
|
17066261 |
2006 |